| SKU: | 2762 |
|---|---|
| Generic For: | Imatinib |
| Active Ingredient: | Imatinib |
| Manufacturer: | Intas Pharma, India |
Imat 400 mg (Imatinib) Tablet – Generic for Cancer Treatment
Imat 400mg is a prescription-based oral medicine containing Imatinib as its main active ingredient. The medicine belongs to the class of drugs known as tyrosine kinase inhibitors (TKIs), a targeted therapy agents that work at a molecular level to disrupt cancer cell proliferation.
Doctors prescribe Imat 400mg tablets for several serious medical conditions.
Uses of Imat 400mg tablet (Imatinib)
Imat 400mg tablet (Imatinib) is a targeted therapy medication used to treat several types of cancers and blood disorders. Its most common use is in the treatment of Chronic myeloid leukemia (CML), a type of blood cancer. It is often the first-line treatment for adults and children diagnosed with Philadelphia chromosome-positive CML, helping to control the disease and improve long-term outcomes when started early. Imat 400mg is also prescribed for certain cases of Acute lymphoblastic leukemia (ALL) that carry the BCR-ABL gene mutation, where it works by slowing the growth of abnormal cancer cells.
Additionally, it is used to treat Gastrointestinal stromal tumors (GIST), a rare cancer of the digestive tract, helping shrink tumors, slow tumor progression, and improve survival in patients with inoperable or metastatic disease.
The medication may also be recommended for Dermatofibrosarcoma protuberans (DFSP), a rare type of skin cancer, especially when surgery is not possible, or the cancer has recurred. It is also found that this medicine is effective in managing certain Myelodysplastic/myeloproliferative disorders (MDS/MPD) associated with PDGFR gene abnormalities by regulating abnormal blood cell production. Doctors often prescribe this medicine in selected cases of Aggressive systemic mastocytosis (ASM) as well, a rare condition characterized by an excessive buildup of mast cells, particularly when other treatment options have not provided adequate results. Always use Imat 400mg under the guidance of a qualified healthcare professional.
Imat 400mg is widely recognized as a gold-standard treatment in oncology, manufactured by Zydus Healthcare Ltd. Its precision mechanism makes it one of the most studied and prescribed anti-cancer drugs globally, with over two decades of clinical evidence supporting its safety and efficacy.
Buy Imat 400mg tablets online at AllDayChemist and get a trusted, affordable source for Imatinib mesylate, a frontline oral cancer medication. With secure ordering, discreet packaging, and worldwide shipping, AllDayChemist makes it simple to access life-saving oncology medicines from the comfort of home.
How does Imat 400mg work?
Imat 400mg works by selectively blocking abnormal tyrosine kinase proteins, specifically BCR-ABL, c-Kit, and PDGFR, that drive uncontrolled cancer cell division. Unlike traditional chemotherapy that attacks all rapidly dividing cells, Imatinib is a targeted therapy: it zeroes in on cancer-specific proteins, leaving healthy cells relatively unaffected.
This precision action results in:
- Suppression of cancer cell growth and multiplication
- Induction of apoptosis (programmed cell death) in cancer cells
- Reduced tumor size in GIST patients
- Achievement of complete cytogenetic response in CML patients
Important precautions before taking Imatinib 400mg
- Pregnancy: Imat 400mg is contraindicated during pregnancy. It may cause serious fetal harm. Effective contraception is essential during and for at least 15 days after treatment.
- Breastfeeding: Not recommended. Imatinib passes into breast milk.
- Grapefruit: Avoid grapefruit and grapefruit juice; they can elevate imatinib blood levels and increase side-effect risk.
- Drug interactions: Imatinib interacts with CYP3A4-metabolized drugs (warfarin, certain statins, anticonvulsants). Share your full medication list with your doctor.
- Liver/kidney impairment: Dose adjustment may be needed. Regular monitoring is essential.
Imatinib 400mg side effects
Like all oncology medications, Imat 400mg may cause side effects. Most are manageable and tend to decrease over time. The most commonly reported side effects are nausea and vomiting, fluid retention or swelling (particularly around the eyes and legs), muscle cramps and joint pain, diarrhea or abdominal discomfort, skin rashes or itchiness, fatigue and headache, and hair thinning.
Serious side effects require seeking immediate medical attention. Speak to your doctor if you experience any of the following side effects:
- Severe fluid retention (pleural effusion, pulmonary edema)
- Liver toxicity (yellowing of skin/eyes, dark urine)
- Severe skin reactions
- Low blood cell counts (increased infection risk, unusual bruising/bleeding)
- Heart failure (rare)
Inform your oncologist of any persistent or severe side effects you experience. Blood counts and liver function tests are routinely monitored during treatment.
Imatinib 400mg dosage and how to take it
Always follow your oncologist's prescribed dosage. General guidelines include:
- CML (chronic Phase): 400mg once daily orally
- CML (accelerated or blast phase): 600mg once daily
- GIST (unresectable/metastatic): 400mg once daily; may be increased to 600–800mg/day based on response
- ALL (Ph+): 600mg once daily in combination with chemotherapy
How to take: Take the tablet with a large glass of water, preferably with a meal, at the same time each day to maintain consistent drug levels in your bloodstream. Do not crush or chew the tablet. If you miss a dose, take it as soon as you remember, unless it's nearly time for the next dose.
What is Imat 400mg tablet used for?
Imat 400mg is a prescription oral cancer medication containing Imatinib, used primarily to treat chronic myeloid leukemia, a type of blood cancer, particularly in patients with the Philadelphia chromosome-positive form of the disease. It is also prescribed for certain cases of acute lymphoblastic leukemia carrying a specific gene mutation, gastrointestinal stromal tumors affecting the digestive tract, and rare conditions such as dermatofibrosarcoma protuberans, a type of skin cancer. Imat 400mg belongs to a class of targeted cancer therapies called tyrosine kinase inhibitors and is manufactured by Zydus Healthcare. With over two decades of clinical use, it remains one of the most extensively studied targeted cancer treatments available.
How does Imat 400mg target cancer cells specifically?
Imat 400mg works by selectively blocking abnormal tyrosine kinase proteins, including BCR-ABL, c-Kit, and PDGFR, that drive uncontrolled growth in certain cancer cells. Unlike traditional chemotherapy, which affects many types of rapidly dividing cells throughout the body, Imatinib is a targeted therapy that specifically targets these cancer-related proteins, generally sparing healthy cells more than older treatments. This precise action helps suppress cancer cell growth, triggers programmed cell death in cancer cells, and can reduce tumour size in conditions such as gastrointestinal stromal tumours. Many patients with chronic myeloid leukemia achieve a complete cytogenetic response, meaning no detectable abnormal cells, with consistent long-term treatment.
How long does it typically take to see results from Imat 400mg treatment?
Response to Imat 400mg is usually monitored over weeks to months through regular blood tests and specialised genetic monitoring rather than by how a patient feels day to day. In chronic myeloid leukemia, doctors often look for early hematologic response within the first few weeks, followed by deeper molecular and cytogenetic responses that can take several months to a year or longer to fully develop. Treatment response varies based on the specific condition, disease stage, and individual patient factors. Oncologists use these test results to determine whether the current dose is working effectively or whether adjustments to the treatment plan are needed.
What is the standard dosing for Imat 400mg across different conditions?
Dosing for Imat 400mg varies depending on the condition being treated. For chronic phase chronic myeloid leukemia, the typical dose is 400mg once daily, while accelerated or blast phase disease may require 600mg daily. Gastrointestinal stromal tumors that are unresectable or metastatic are often treated starting at 400mg daily, which may be increased to 600 to 800mg per day based on response. Philadelphia chromosome-positive acute lymphoblastic leukemia is often treated with 600mg daily in combination with chemotherapy. The tablet should be taken with a large glass of water, generally with a meal, at the same time each day, and never adjusted without an oncologist's direct guidance.
Is Imat 400mg safe for long-term cancer management?
Imat 400mg has an extensive long-term safety record, with many patients with chronic myeloid leukemia continuing treatment for years as part of ongoing disease management. Long-term use requires regular monitoring through blood counts, liver function tests, and periodic clinical evaluations to track both treatment effectiveness and any emerging side effects. Some patients may eventually be considered for treatment-free remission under very specific clinical criteria, but this decision is made exclusively by the treating oncologist based on sustained deep molecular response. Long-term safety and the possibility of dose adjustment or discontinuation should always be discussed directly with the cancer care team rather than decided independently.
What precautions are important before and during Imat 400mg treatment?
Imat 400mg is not recommended during pregnancy due to the risk of serious harm to a developing fetus, and effective contraception is necessary during treatment and for at least fifteen days afterward. It is also not recommended while breastfeeding, since Imatinib passes into breast milk. Grapefruit and grapefruit juice should be avoided, as they can raise Imatinib levels in the blood and increase the risk of side effects. Patients should disclose all current medications, as Imatinib interacts with several drugs metabolised via similar hepatic pathways, including certain blood thinners, statins, and anticonvulsants. Those with existing liver or kidney impairment may require dose adjustments and closer monitoring.
What are the most common side effects of Imat 400mg?
The most commonly reported side effects of Imat 400mg include nausea and vomiting, fluid retention or swelling, particularly around the eyes and legs, muscle cramps, joint pain, diarrhea or abdominal discomfort, skin rashes or itchiness, fatigue, headache, and mild hair thinning. Most of these effects are manageable and tend to decrease over the course of treatment as the body adjusts. Taking the tablet with food and a full glass of water can help reduce gastrointestinal discomfort. Any side effect that becomes severe, persistent, or significantly affects daily life should be discussed with the oncology team, since supportive treatments or dose adjustments are often available.
What serious side effects of Imat 400mg require urgent medical care?
Serious side effects requiring immediate medical attention include significant fluid buildup around the lungs or heart, signs of liver toxicity such as yellowing of the skin or eyes and dark urine, severe skin reactions, unusually low blood cell counts leading to increased infection risk or unexplained bruising and bleeding, and, rarely, signs of heart failure. Regular blood counts and liver function tests are routine parts of treatment monitoring, specifically to catch these issues early, often before symptoms become severe. Any new or worsening symptom, particularly related to breathing, swelling, or unusual bleeding, should be reported to the oncology team without delay.
What should be done if a dose of Imat 400mg is missed?
If a dose of Imat 400mg is missed, it should be taken as soon as it is remembered, unless it is nearly time for the next scheduled dose, in which case the missed dose should be skipped rather than doubled up. Maintaining consistent daily dosing helps keep stable drug levels in the bloodstream, which is important for ongoing suppression of cancer cell activity. Patients who frequently miss doses or have difficulty maintaining the schedule should discuss this openly with their oncology team, since missed doses over time can affect how well the cancer is controlled and may influence treatment decisions.
How does Imat 400mg compare to other targeted leukemia therapies like Dasatinib or Nilotinib?
Imat 400mg, containing Imatinib, was the first targeted tyrosine kinase inhibitor approved for chronic myeloid leukemia and remains a common first-line treatment choice. Newer tyrosine kinase inhibitors such as Dasatinib and Nilotinib are sometimes used as alternatives, particularly if a patient does not respond adequately to Imatinib, develops resistance over time, or experiences intolerable side effects. Each medication has a different side effect profile and dosing schedule, and the choice between them depends on individual patient factors, disease genetics, and treatment history. Switching between these therapies is a decision made by an oncologist based on detailed monitoring of treatment response.
Can older adults safely take Imat 400mg for cancer treatment?
Yes, Imat 400mg can be used in older adults, though dosing and monitoring are often individualized more carefully due to age-related differences in organ function and the increased likelihood of other existing health conditions. Older patients may be more susceptible to certain side effects, such as fluid retention, and may require more frequent monitoring of heart and kidney function during treatment. Coordinating Imatinib treatment with any other medications being taken for age-related conditions, such as high blood pressure or heart disease, is particularly important to avoid interactions. An oncologist will weigh the benefits and risks carefully when determining the appropriate treatment plan for elderly patients.
Is it safe to buy Imat 400mg online, and how is delivery handled?
Yes, Imat 400mg can be safely purchased online through a licensed pharmacy such as AllDayChemist, which sources authentic medication from established manufacturers including Intas Pharma. As a prescription oncology medication, a valid prescription is required before ordering. AllDayChemist ships to customers in the USA, UK, Australia, Canada, and many other countries with secure, discreet packaging designed for sensitive medical shipments. Given the often substantial cost of cancer medications, ordering generic Imatinib online can provide significant savings compared to brand-name prices, which matters considerably for patients managing long-term oncology treatment costs. Support is available for questions about authenticity, shipping, and order tracking.
Leading Online Pharmacy
100% Genuine
Products
& OTC Products
Login
Sign up
Leading Online Pharmacy
100% Genuine
Products
& OTC Products
Login
Sign Up
Leading Online Pharmacy
100% Genuine
Products
& OTC Products
Forgot Password ?